Gumboro Disease Market — Trends, Outlook, 2025

@

Gumboro disease also called as Infectious bursal disease (IBD) is a viral disease caused by Infectious Bursal Disease Virus (IBDV), which mostly targets the immune system of chickens. This disease was first observed in area Gumboro of Delaware, U.S.A., so called as Gumboro disease. It can be seen in turkeys and ducks without immunosuppression. It is a highly contagious disease occurring in chickens older than 3 weeks. Infected chicken may have the symptoms such staining of feathers around the vent with feces and several urates, ruffled feathers, anorexia dehydration in the pectoral, thigh and abdominal muscles, and impaired kidneys by chronic urate diathesis. Subclinical infection might results in deficiency in immunological response to Infectious Bronchitis, Newcastle disease, Marek’s disease, and susceptibility to gangrenous dermatitis and Inclusion Body Hepatitis. Supplement of multivitamin and facilitating access to water might help in curing the disease, as treatment of this disease is not available. Preventive measures such as vaccination helps in the Gumboro disease.

High transmission rate of gumboro disease and rising need to prevent it, are the important factors contributing to the growth of gumboro disease market

Increasing prevalence rate of Gumboro disease is affecting the poultry industry drastically. This is a contiguous disease and it is easy to transmit through all the poultry area, as infected chickens sheds the infection in their feces resulting in to the loss of poultry business. Treatment requirement for Gumboro disease to reduce loss is driving the growth of Gumboro disease market. According to the data published by Science Alert in 2013, economic loss due to Gumboro disease in Nigeria for 2009, 2010, and 2011 accounted for more than 3 billion Nigerian currency. According to the data published by Centre d’etudes et de Recherché, Belgium in 2000, the mortality rate due to Gumboro disease in the U.S. was 5% whereas in Japan and Europe the rate is high 50% to 60% in laying hens and 25% to 30% in broilers.

However, increase in research and developments with new vaccines in the pipeline for the prevention from Gumboro disease is expected to propel the Gumboro disease market. For instance, the Transmune IBD vaccines available by CEVA manufacturers has proven effective for Gumboro disease.

Request For Sample Copy@

https://www.coherentmarketinsights.com/insight/request-sample/783

New vaccine development and their effective results are accounting for the larger share of vaccine segment in gumboro disease market

The global gumboro disease market is segmented by species type, by vaccines type and by region

On the basis of species type, the Gumboro Disease Market is segmented into:

Broilers,layers

On the basis of vaccines type, the Gumboro disease market is segmented into:

conventional vaccines,antibody/ antigen complex vaccines,vectored vaccines

High rate of chicken consumers in North America is the driving factor for gumboro disease market in this region

Regional segmentation of Gumboro Disease Market by Coherent Market Insights comprises of North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds the major share in the Gumboro disease market due to the high prevalence of gumboro disease and increasing investment in the research and development. The U.S. is the largest broiler chicken industry in the world. According to National Chicken Council, in 2015, there was around 9 billion production of broiler chicken in the U.S. The chicken consumers are more in this region than any other regions in world, so the chances of poultry industry getting affected by Gumboro disease and loss caused by it is more in America, which is driving the growth of gumboro disease market in North America.

Rapid development in the field of vaccinology and novel biotechnology tools are helping the industry players to progress in the gumboro disease market

Key industry players operating the Gumboro Disease Market includes Ceva, ROMVAC Company SA, PTSanbe Farma, Jiangyin Caina Technology co. limited, Cios Co., Salfarm Danmark A/s., Vetbiochem, and others. Growing research and development in the vaccine technology field and increase in rate of gumboro disease is encouraging the vaccine manufacturers to invest in gumboro disease market. Rapid development in the area of immunology, animal science, and biotechnology is giving rise to new biotechnology tools for helping the industry players to sustain in the gumboro disease market.

Ask For the Discount@

https://www.coherentmarketinsights.com/insight/request-discount/783

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging